Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.13 - $3.69 $338,999 - $1.11 Million
-300,000 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$3.64 - $7.76 $145,600 - $310,400
40,000 Added 15.38%
300,000 $1.26 Million
Q2 2020

Aug 10, 2020

BUY
$4.78 - $8.26 $382,400 - $660,800
80,000 Added 44.44%
260,000 $1.8 Million
Q1 2020

May 12, 2020

BUY
$4.0 - $21.53 $484,000 - $2.61 Million
121,000 Added 205.08%
180,000 $720,000
Q1 2019

May 03, 2019

BUY
$12.61 - $22.33 $239,590 - $424,269
19,000 Added 47.5%
59,000 $1.23 Million
Q3 2018

Nov 01, 2018

BUY
$2.45 - $16.27 $98,000 - $650,800
40,000 New
40,000 $651,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $238M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.